ym 022 has been researched along with brl 37344 in 1 studies
| Studies (ym 022) | Trials (ym 022) | Recent Studies (post-2010) (ym 022) | Studies (brl 37344) | Trials (brl 37344) | Recent Studies (post-2010) (brl 37344) |
|---|---|---|---|---|---|
| 65 | 1 | 8 | 290 | 0 | 46 |
| Protein | Taxonomy | ym 022 (IC50) | brl 37344 (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 5 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.8697 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attoub, S; Bado, A; Barbier, M; Cherbut, C; Galmiche, JP; Joubert, M; Laboisse, C | 1 |
1 other study(ies) available for ym 022 and brl 37344
| Article | Year |
|---|---|
Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Benzodiazepines; Colitis; Disease Models, Animal; Ethanolamines; Hormone Antagonists; Inflammatory Bowel Diseases; Leptin; Male; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Adrenergic, beta-3; Receptors, Cholecystokinin; Severity of Illness Index | 2001 |